Patients and treatments in a neuropalliative outpatient clinic: an analysis of clinical routine data from five years of care.
Abstract
[INTRODUCTION] The increasing prevalence of life-threatening neurological diseases raises the need for neuropalliative care. Setting up neurological palliative outpatient clinics is one way of addressing this need. This study aims to describe the patient clientele of a neurological palliative outpatient clinic and the spectrum of necessary treatments and interventions.
[METHODS] In this longitudinal analysis, clinical routine data from a single centre were collected retrospectively from adult patients. The patient characteristics related to disease and treatment were evaluated descriptively. Factors influencing the need for ventilation were modelled in a logistic regression. The required treatment effort was modelled with a zero-inflated Beta regression. Results were reported as odds ratios with 95% confidence intervals (CIs).
[RESULTS] Two hundred and thirty-two patients were included in the study. Ninety-one patients were women, 141 were men, and the mean age was 55.42 years. Neuropalliative patients represented diagnoses such as amyotrophic lateral sclerosis (ALS) (n = 81), ischemic stroke (n = 15), intracerebral haemorrhage (n = 15), Duchenne muscular dystrophy (n = 12), or craniocerebral trauma (n = 10). Palliative care counselling was the most common intervention for patients (n = 203), their close relatives (n = 177), and their nursing services (n = 75). Respiratory therapy (n = 188), speech and language therapy (n = 145), and physiotherapy (n = 143) were also frequently applied interventions. Sixty patients received botulinum toxin A treatment for hypersalivation, and 32 for spasticity. The odds of needing invasive ventilation increased by 3.7 (CI 1.7-7.8), and the need for mechanical insufflation-exsufflation increased by 2.2 (CI 1.1-4.3) in patients previously discharged from early neurological-neurosurgical rehabilitation. Prior intensive care treatment increased the odds of invasive ventilation by 5.1 (CI 2.2-11.5) and the use of mechanical insufflation-exsufflation by 2.3 (CI 1.1-4.8).
[CONCLUSION] Neuropalliative outpatient clinics demand a wide range of diagnostic measures and interventions as well as a multidisciplinary approach. Further research is necessary to investigate the relation between diagnosis and treatment needs.
[CLINICAL TRIAL REGISTRATION] https://drks.de/search/en/trial/DRKS00030778, identifier DRKS00030778.
[METHODS] In this longitudinal analysis, clinical routine data from a single centre were collected retrospectively from adult patients. The patient characteristics related to disease and treatment were evaluated descriptively. Factors influencing the need for ventilation were modelled in a logistic regression. The required treatment effort was modelled with a zero-inflated Beta regression. Results were reported as odds ratios with 95% confidence intervals (CIs).
[RESULTS] Two hundred and thirty-two patients were included in the study. Ninety-one patients were women, 141 were men, and the mean age was 55.42 years. Neuropalliative patients represented diagnoses such as amyotrophic lateral sclerosis (ALS) (n = 81), ischemic stroke (n = 15), intracerebral haemorrhage (n = 15), Duchenne muscular dystrophy (n = 12), or craniocerebral trauma (n = 10). Palliative care counselling was the most common intervention for patients (n = 203), their close relatives (n = 177), and their nursing services (n = 75). Respiratory therapy (n = 188), speech and language therapy (n = 145), and physiotherapy (n = 143) were also frequently applied interventions. Sixty patients received botulinum toxin A treatment for hypersalivation, and 32 for spasticity. The odds of needing invasive ventilation increased by 3.7 (CI 1.7-7.8), and the need for mechanical insufflation-exsufflation increased by 2.2 (CI 1.1-4.3) in patients previously discharged from early neurological-neurosurgical rehabilitation. Prior intensive care treatment increased the odds of invasive ventilation by 5.1 (CI 2.2-11.5) and the use of mechanical insufflation-exsufflation by 2.3 (CI 1.1-4.8).
[CONCLUSION] Neuropalliative outpatient clinics demand a wide range of diagnostic measures and interventions as well as a multidisciplinary approach. Further research is necessary to investigate the relation between diagnosis and treatment needs.
[CLINICAL TRIAL REGISTRATION] https://drks.de/search/en/trial/DRKS00030778, identifier DRKS00030778.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 1 | |
| 해부 | intracerebral
|
scispacy | 1 | ||
| 약물 | [INTRODUCTION] The
|
scispacy | 1 | ||
| 약물 | [RESULTS] Two
|
scispacy | 1 | ||
| 질환 | neurological diseases
|
C0027765
nervous system disorder
|
scispacy | 1 | |
| 질환 | Neuropalliative
|
scispacy | 1 | ||
| 질환 | amyotrophic lateral sclerosis
|
C0002736
Amyotrophic Lateral Sclerosis
|
scispacy | 1 | |
| 질환 | ALS
→ amyotrophic lateral sclerosis
|
C0002736
Amyotrophic Lateral Sclerosis
|
scispacy | 1 | |
| 질환 | ischemic stroke
|
C0948008
Ischemic stroke
|
scispacy | 1 | |
| 질환 | intracerebral haemorrhage
|
C2937358
Cerebral Hemorrhage
|
scispacy | 1 | |
| 질환 | Duchenne muscular dystrophy
|
C0013264
Muscular Dystrophy, Duchenne
|
scispacy | 1 | |
| 질환 | craniocerebral trauma
|
C0018674
Craniocerebral Trauma
|
scispacy | 1 | |
| 질환 | hypersalivation
|
C0037036
Sialorrhea
|
scispacy | 1 | |
| 질환 | spasticity
|
C0026838
Muscle Spasticity
|
scispacy | 1 | |
| 질환 | disease
|
scispacy | 1 | ||
| 질환 | CIs
→ confidence intervals
|
scispacy | 1 | ||
| 질환 | Duchenne muscular
|
scispacy | 1 | ||
| 기타 | Patients
|
scispacy | 1 | ||
| 기타 | patient
|
scispacy | 1 | ||
| 기타 | women
|
scispacy | 1 | ||
| 기타 | men
|
scispacy | 1 | ||
| 기타 | amyotrophic lateral
|
scispacy | 1 | ||
| 기타 | botulinum toxin A
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.